Metagenomi, Inc. Common Stock (MGX) vs Precipio, Inc. (PRPO)
A side-by-side comparison of Metagenomi, Inc. Common Stock and Precipio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGX
Metagenomi, Inc. Common Stock
$1.04HealthcareDelayed quote: Oct 6, 2026, 2:12 PM EDT
PRPO
Precipio, Inc.
$23.41HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
Total return — MGX vs PRPO
growth of $100 · dividends reinvested · last 3yMGX -89.9% (-53.4%/yr)PRPO +270.4% (+54.7%/yr)PRPO compounded faster over this window
Log scale — wide-divergence pair
MGX PRPO
MGX vs PRPO: by the numbers
- •PRPO is the larger company ($42M vs $39M market cap).
- •Both run net losses; PRPO's is the smaller (-4.42% vs -689.20% net margin).
Metrics side by side
Valuation
| Metric | MGX | PRPO |
|---|---|---|
| P/S ratio | 2.87 | 1.52 |
| P/B ratio | 0.35 | 2.83 |
| FCF yield | N/A | 1.89% |
Profitability
| Metric | MGX | PRPO |
|---|---|---|
| Gross margin | 74.29% | 43.69% |
| Operating margin | -380.85% | -5.63% |
| Net margin | -689.20% | -4.42% |
| ROE | -83.03% | -8.23% |
| ROIC | -66.03% | -8.43% |
Growth (annualized)
| Metric | MGX | PRPO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 28.84% |
| Total return CAGR (5Y) | N/A | -14.46% |
Go deeper
Dig into the metrics
Metagenomi, Inc. Common Stock ROEPrecipio ROEMetagenomi, Inc. Common Stock operating marginPrecipio operating marginMetagenomi, Inc. Common Stock revenue growthPrecipio revenue growthMetagenomi, Inc. Common Stock free cash flowPrecipio free cash flow
Metagenomi, Inc. Common Stock & Precipio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.